CDC expands booster rollout, Dr. Avula says Virginia is prepared

Coronavirus

WASHINGTON (AP/WRIC) — Millions more Americans can get a COVID-19 booster and choose a different company’s vaccine for that next shot, federal health officials said Thursday.

Certain people who received Pfizer vaccinations months ago already are eligible for a booster and now the Centers for Disease Control and Prevention says specific Moderna and Johnson & Johnson recipients qualify, too.

Dr. Danny Avula, Virginia’s vaccine coordinator, said in a press release, “VDH has been working with our vaccination partners — pharmacies, healthcare providers, hospitals and other institutions — to prepare for the booster rollout.”

Both the Moderna and Johnson & Johnson booster shots are now available across Virginia, according to the Virginia Department of Health (VDH).

When Do I Get a Booster?

According to guidance from VDH and the CDC, whether or not you need a booster now depends on how long it’s been since you were vaccinated – and which version of the vaccine you received.

Starting six months past their last Pfizer or Moderna vaccination, people are urged to get a booster if they meet the following criteria:

  • Aged 65 or older
  • Resident of a nursing home
  • At least 50 and at increased risk of severe disease because of health problems.

Moderna’s booster will come at half the dose of the original two shots.

As for recipients of the single-shot J&J vaccine, a COVID-19 booster is recommended for everyone at least two months after their vaccination. That’s because the J&J vaccine hasn’t proved as protective as the two-dose Moderna or Pfizer options.

Boosters are also allowed, but not urged, for adults of any age at increased risk of infection because of health problems or their jobs or living conditions. That includes health care workers, people with compromised immune systems, teachers and people in jails or homeless shelters.

The Food and Drug Administration had already authorized such an expansion of the nation’s booster campaign on Wednesday, and it was also endorsed Thursday by a CDC advisory panel. CDC Director Dr. Rochelle Walensky had the final word on who gets the extra doses.

“These past 20 months have taught us many things, but mostly to have humility,” she told the panel. “We are constantly learning about this virus, growing the evidence base and accumulating more data.”

Mix and Match

In a bigger change, the agency is allowing the flexibility of “mixing and matching” that extra dose regardless of which type people received first.

The CDC panel didn’t explicitly recommend anyone get a different brand than they started with but left open the option — saying only that a booster of some sort was recommended. And some of the advisers said they would prefer that J&J recipients receive a competitor’s booster, citing preliminary data from an ongoing government study that suggested a bigger boost in virus-fighting antibodies from that combination.

“We’re at a different place in the pandemic than we were earlier” when supply constraints meant people had to take whatever shot they were offered, noted CDC adviser Dr. Helen Keipp Talbot of Vanderbilt University.

She called it “priceless” to be able to choose a different kind for the booster if, for example, someone might be at risk for a rare side effect from a specific vaccine.

“If you decide to get a booster dose by mixing and matching, VDH urges you to consult with your doctor or healthcare provider who can assist you in making the best decision for your own situation,” said Dr. Avula.

About two-thirds of Americans eligible for COVID-19 shots are fully vaccinated, and the government says getting first shots to the unvaccinated remain the priority. While health authorities hope boosters will shore up waning immunity against milder coronavirus infections, all the vaccines still offer strong protection against hospitalizations and death, even as the extra-contagious delta variant burned through the country.

And CDC’s advisers wrestled with whether people who didn’t really need boosters might be getting them, especially young, otherwise healthy adults whose only qualification was their job.

Dr. Sarah Long of Drexel University voiced concerns about opening those people to rare but serious side effects from another dose if they already were adequately protected.

“I have my own concerns that we appear to be recommending vaccines for people who I don’t think need it,” added Dr. Beth Bell of the University of Washington.

But she stressed that the vaccines work and that moving forward with the recommendations makes sense for the sake of being clear and allowing flexibility when it comes to boosters.

Despite the concerns by some members, the panels’ votes ended up being unanimous.

The vast majority of the nearly 190 million Americans who are fully vaccinated against COVID-19 have received the Pfizer or Moderna options, while J&J recipients account for only about 15 million.

___

The Associated Press Health & Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

StormTracker 8

Trending Stories

More Trending Stories

Local Events